Rivaroxaban 10 MG Oral Tablet — RxCUI 1114198
RxNorm drug concept · Semantic clinical drug
RxCUI 1114198
Semantic clinical drug · SCD
● Current RxNorm concept 29 FDA products
77 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1114198
Official nameRivaroxaban 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped29
Package NDCs mapped77
Reported Medicaid activity (SDUD)651,193 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Rivaroxaban: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, rivaroxaban is a blood thinner, but it covers a pretty wide range of conditions. It's used to treat blood clots in the legs (DVT) and lungs (pulmonary embolism), prevent those...
- What exactly is rivaroxaban used for — is it just a blood thinner?
- It depends on the strength you've been prescribed. Certain higher-strength tablets need to be taken with food — food helps your body absorb enough of the medication. Lower-strength...
- Do I need to take rivaroxaban with food?
🕸️ Concept Web — How Rivaroxaban 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Rivaroxaban 10 MG Oral Tablet
RxCUI 1114198 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Rivaroxaban
1114195IN
-
Rivaroxaban
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xarelto
1114199BN
-
Xarelto
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Rivaroxaban Oral Tablet
1114197SCDF -
Rivaroxaban Oral Product
1157968SCDG -
Rivaroxaban Pill
1157969SCDG -
Rivaroxaban Oral Tablet [Xarelto]
1114201SBDF -
Xarelto Oral Product
1186304SBDG -
Xarelto Pill
1186305SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Rivaroxaban Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Rivaroxaban 10 MG
1114196SCDC -
Rivaroxaban 10 MG Oral Tablet [Xarelto]
1114202SBD -
Rivaroxaban 10 MG [Xarelto]
1114200SBDC
-
Rivaroxaban 10 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Rivaroxaban 10 MG
SCDC · 1114196 -
Rivaroxaban Oral Tablet
SCDF · 1114197 -
Rivaroxaban Oral Product
SCDG · 1157968 -
Rivaroxaban Pill
SCDG · 1157969
Brand-Name Concepts
-
Rivaroxaban 10 MG Oral Tablet [Xarelto]
SBD · 1114202 -
Rivaroxaban 10 MG [Xarelto]
SBDC · 1114200 -
Rivaroxaban Oral Tablet [Xarelto]
SBDF · 1114201 -
Xarelto Oral Product
SBDG · 1186304 -
Xarelto Pill
SBDG · 1186305 -
Xarelto
BN · 1114199
📦 FDA Products & Package NDCs
29 products · 77 package NDCs
77 package NDCs map to RxCUI 1114198 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50458-0580-90 | 90 TABLET, FILM COATED in 1 BOTTLE (50458-580-90) | Xarelto | Janssen Pharmaceuticals, Inc. | 2017-11-01 |
| 50458-0584-51 | 1 KIT in 1 CARTON (50458-584-51) * 42 TABLET, FILM COATED... | XARELTO | Janssen Pharmaceuticals, Inc. | 2014-09-16 |
| 50458-0584-52 | 1 KIT in 1 CARTON (50458-584-52) * 42 TABLET, FILM COATED... | XARELTO | Janssen Pharmaceuticals, Inc. | 2016-11-01 |
| 55154-1422-00 | 10 BLISTER PACK in 1 BAG (55154-1422-0) / 1 TABLET, FILM CO... | Xarelto | Cardinal Health 107, LLC | 2011-07-01 |
| 55154-1423-08 | 4440 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-1423-8) | Xarelto | Cardinal Health 107, LLC | 2011-11-05 |
| 55154-1424-08 | 2070 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-1424-8) | Xarelto | Cardinal Health 107, LLC | 2011-11-04 |
| 55488-0540-01 | 30 TABLET, FILM COATED in 1 BOTTLE (55488-0540-1) | rivaroxaban | Changzhou Pharmaceutical Factory | 2026-02-01 |
| 55488-0541-01 | 30 TABLET, FILM COATED in 1 BOTTLE (55488-0541-1) | rivaroxaban | Changzhou Pharmaceutical Factory | 2026-02-01 |
| 55488-0542-01 | 30 TABLET, FILM COATED in 1 BOTTLE (55488-0542-1) | rivaroxaban | Changzhou Pharmaceutical Factory | 2026-02-01 |
| 62332-0240-51 | 1 KIT in 1 CARTON (62332-240-51) * 42 TABLET, FILM COATED... | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0346-10 | 100 BLISTER PACK in 1 CARTON (62332-346-10) / 10 TABLET, FI... | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0346-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-346-30) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0346-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-346-90) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0346-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-346-91) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0347-10 | 100 BLISTER PACK in 1 CARTON (62332-347-10) / 10 TABLET, FI... | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0347-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-347-30) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0347-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-347-90) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0347-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-347-91) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0348-10 | 100 BLISTER PACK in 1 CARTON (62332-348-10) / 10 TABLET, FI... | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0348-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-348-30) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0348-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-348-90) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0348-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-348-91) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0683-10 | 100 BLISTER PACK in 1 CARTON (62332-683-10) / 10 TABLET, FI... | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0683-45 | 180 TABLET, FILM COATED in 1 BOTTLE (62332-683-45) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0683-60 | 60 TABLET, FILM COATED in 1 BOTTLE (62332-683-60) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 62332-0683-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-683-91) | RIVAROXABAN | Alembic Pharmaceuticals Inc. | 2025-05-14 |
| 71610-0690-42 | 1800 TABLET, FILM COATED in 1 BOTTLE (71610-690-42) | Xarelto | Aphena Pharma Solutions - Tennessee, LLC | 2023-02-17 |
Observed labelers:
Janssen Pharmaceuticals, Inc. (20) ·
Alembic Pharmaceuticals Inc. (17) ·
Alembic Pharmaceuticals Limited (17) ·
Indoco Remedies Limited (13) ·
A-S Medication Solutions (3) ·
Cardinal Health 107, LLC (3)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.